Retraction notice to “Increased levels of Th17 cells are associated with non-neuronal acetylcholine in COPD patients” [Immunobiology 219(5) (2014) 392–401, (S0171298514000138), (10.1016/j.imbio.2014.01.004)];Increased levels of Th17 cells are associated with non-neuronal acetylcholine in COPD patients

Immunobiology

Volumn 219, Issue 5, 2014, Pages 392-401

  Profita, Mirella ^a   Albano, Giusy Daniela ^a,b   Riccobono, Loredana ^a   Di Sano, Caterina ^a   Montalbano, Angela Marina ^a   Gagliardo, Rosalia ^a   Anzalone, Giulia ^a   Bonanno, Anna ^a   Pieper, Michael Paul ^c   Gjomarkaj, Mark ^a  

^a CNR Consiglio Nazionale delle Ricerche   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

^c BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

Anticholinergic drugs; Beta 2 long acting; Systemic inflammation; Th; Th 17 cells

Indexed keywords

ACETYLCHOLINE; INTERLEUKIN 17; INTERLEUKIN 22; RETINOID RELATED ORPHAN RECEPTOR GAMMA; TRANSCRIPTION FACTOR FOXP3;

ADULT; ARTICLE; CD3+ T LYMPHOCYTE; CELL STIMULATION; CELL SURFACE; CHOLINERGIC SYSTEM; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; HUMAN; IN VITRO STUDY; MALE; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; TH17 CELL; UPREGULATION;

ANTICHOLINERGIC DRUGS; BETA-2 LONG ACTING; SYSTEMIC INFLAMMATION; TH-17 CELLS;

ACETYLCHOLINE; AGED; AGED, 80 AND OVER; BENZOXAZINES; CHOLINERGIC ANTAGONISTS; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INTERLEUKIN-17; INTERLEUKINS; INTRACELLULAR SPACE; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 3; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SCOPOLAMINE DERIVATIVES; TH17 CELLS;

EID: 84896398898     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2024.152806     Document Type: Erratum

References (37)

1. Aujla S.J., Chan Y.R., Zheng M., Fei M., Askew D.J., Pociask D.A., Reinhart T.A., McAllister F., Edeal J., Gaus K., Husain S., Kreindler J.L., Dubin P.J., Pilewski J.M., Myerburg M.M., Mason C.A., Iwakura Y., Kolls J.K. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat. Med. 2008, 14(March (3)):275-281.
2. Barcelo B., Pons J., Ferrer J.M., Sauleda J., Fuster A., Agusti A.G.N. Phenotypic characterisation of T-lymphocytes in COPD: abnormal CD4+CD25+ regulatory T-lymphocyte response to tobacco smoking. Eur. Respir. J. 2008, 31:555-562.
3. Belmonte K.E. Cholinergic pathways in the lungs and anticholinergic therapy for chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 2005, 2(4):297-304. (discussion 311-312).
4. Bettelli E., Carrier Y., Gao W., Korn T., Strom T.B., Oukka M., Weiner H.L., Kuchroo V.K. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006, 441(May (7090)):235-238.
5. Chang Y., Nadigel J., Boulais N., Bourbeau J., Maltais F., Eidelman D.H., Hamid Q. CD8 positive T cells express IL-17 in patients with chronic obstructive pulmonary disease. Respiratory Research 2011, 12:43.
6. Chong J., Karner C., Poole P. Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease. Cochrane Database Syst. Rev. 2012, 9:12.
7. Cosio M.G., Majo J., Cosio M.G. Inflammation of the airways and lung parenchyma in COPD: role of T cells. Chest 2002, 121(May (Suppl. 5)):160S-165S.
8. Di Stefano A., Caramori G., Gnemmi I., Contoli M., Vicari C., Capelli A., Magno F., D'Anna S.E., Zanini A., Brun P., Casolari P., Chung K.F., Barnes P.J., Papi A., Adcock I., Balbi B. T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients. Clin. Exp. Immunol. 2009, 157(August (2)):316-324.
9. Eiastein E.M., Williams C.B. The Treg/Th17 cell balance: a new paradigm for autoimmunity. Pediatr. Res. 2009, 65(5 (Pt 2)):26R-31R.
10. Eustace A., Smyth L.J.C., Mitchell L., Williamson K., Plumb J., Singh D. Identification of cells expressing IL-17A and IL-17F in the lungs of patients with COPD. Chest 2011, 139(5):1089-1100.
11. Fujii T., Takada-Takatori Y., Kawashima K. Basic and clinical aspects of non-neuronal acetylcholine: expression of an independent, non-neuronal cholinergic system in lymphocytes and its clinical significance in immunotherapy. J. Pharmacol. Sci. 2008, 106(February (2)):186-192.
12. Gosens R., Rieks D., Meurs H., Ninaber D.K., Rabe K.F., Nanninga J., Kolahian S., Halayko A.J., Hiemstra P.S., Zuyderduyn S. Muscarinic M3 receptor stimulation increases cigarette smoke-induced IL-8 secretion by human airway smooth muscle cells. Eur. Respir. J. 2009, 34(December (6)):1436-1443.
13. Ikeuchi H., Kuroiwa T., Hiramatsu N., Kaneko Y., Hiromura K., Ueki K., Nojima Y. Expression of interleukin-22 in rheumatoid arthritis: potential role as a proinflammatory cytokine. Arthritis Rheum. 2005, 52(April (4)):1037-1046.
14. Ivanov I.I., McKenzie B.S., Zhou L., Tadokoro C.E., Lepelley A., Lafaille J.J., Cua D.J., Littman D.R. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006, 126(September (6)):1121-1133.
15. Johnson M. Combination therapy for asthma: complementary effects of long-acting beta2-agonists and corticosteroids. Curr. Allergy Clin. Immunol. 2002, 15:16-22.
16. Jones C.E., Chan K. Interleukin-17 stimulates the expression of interleukin-8, growth-related oncogene-alpha, and granulocyte-colony-stimulating factor by human airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 2002, 26:748-753.
17. Kao C.Y., Huang F., Chen Y., Thai P., Wachi S., Kim C., Tam L., Wu R. Up-regulation of CC chemokine ligand 20 expression in human airway epithelium by IL-17 through a JAK-in-dependent but MEK/NF-kappaB-dependent signaling pathway. J. Immunol. 2005, 175:6676-6685.
18. Kawashima K., Fujii T. The lymphocytic cholinergic system and its biological function. Life Sci. 2003, 72(March (18/19)):2101-2109.
19. Kawashima K., Fujii T. Expression of non-neuronal acetylcholine in lymphocytes and its contribution to the regulation of immune function. Front. Biosci. 2004, 9(1):2063-2085.
20. Kawashima K., Fujii T. Basic and clinical aspects of non-neuronal acetylcholine: overview of non-neuronal cholinergic systems and their biological significance. J. Pharmacol. Sci. 2008, 106(February (2)):167-173.
21. Karner C., Cates C.J. Long-acting beta(2)-agonist in addition to tiotropium versus either tiotropium or long-acting beta(2)-agonist alone for chronic obstructive pulmonary disease. Cochrane Database Syst. Rev. 2012, 18(April):4.
22. Koenen H.J., Smeets R.L., Vink P.M., van Rijssen E., Boots A.M., Joosten I. Human CD25highFoxp3pos regulatory T-cells differentiate into IL-17 producing cells. Blood 2008, 112:2340-2352.
23. Lee S.H., Goswami S., Grudo A., Song L.Z., Bandi V., Goodnight-White S., Green L., Hacken-Bitar J., Huh J., Bakaeen F., Coxson H.O., Cogswell S., Storness-Bliss C., Corry D.B., Kheradmand F. Antielastin autoimmunity in tobacco smoking-induced emphysema. Nat Med. 2007, 13(May (5)):567-569.
24. Linden A., Hoshino H., Laan M. Airway neutrophils and interleukin-17. Eur. Respir. J. 2000, 15(May (5)):973-977.
25. Nizri E., Irony-Tur-Sinai M., Lory O., Orr-Urtreger A., Lavi E., Brenner T. Activation of the cholinergic anti-inflammatory system by nicotine attenuates neuroinflammation via suppression of Th1 and Th17 responses. J. Immunol. 2009, 183(November (10)):6681-6688.
26. O'Donnell R., Breen D., Wilson S., Djukanovic R. Inflammatory cells in the airways in COPD. Thorax 2006, 61(May (5)):448-454.
27. Ouyang W., Kolls J.K., Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 2008, 28(April (4)):454-467.
28. Pauwels R.A., Buist A.S., Calverley P.M., Jenkins C.R., Hurd S.S. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am. J. Respir. Crit. Care Med. 2001, 163(April (5)):1256-1276.
29. Profita M., Giorgi R.D., Sala A., Bonanno A., Riccobono L., Mirabella F., Gjomarkaj M., Bonsignore G., Bousquet J., Vignola A.M. Muscarinic receptors, leukotriene B4 production and neutrophilic inflammation in COPD patients. Allergy 2005, 60(November (11)):1361-1369.
30. Profita M., Bonanno A., Siena L., Ferraro M., Montalbano A.M., Pompeo F., Riccobono L., Pieper M.P., Gjomarkaj M. Acetylcholine mediates the release of IL-8 in human bronchial epithelial cells by a NFkB/ERK-dependent mechanism. Eur. J. Pharmacol. 2008, 582(March (1-3)):145-153.
31. Profita M., Bonanno A., Montalbano A.M., Albano G.D., Riccobono L., Siena L., Ferraro M., Casarosa P., Pieper M.P., Gjomarkaj M. Beta(2) long-acting and anticholinergic drugs control TGF-beta1-mediated neutrophilic inflammation in COPD. Biochim. Biophys. Acta 2012, 1822(July (7)):1079-1089.
32. Profita M., Riccobono L., Montalbano A.M., Bonanno A., Ferraro M., Albano G.D., Gerbino S., Casarosa P., Pieper M.P., Gjomarkaj M. b In vitro anticholinergic drugs affect CD8+ peripheral blood T-cells apoptosis in COPD. Immunobiology 2012, 217(March (3)):345-353.
33. Qian J., Galitovskiy V., Chernyavsky A., Marchenko S., Grando S.A. Plasticity of the murine spleen T-cell cholinergic receptors and their role in in vitro differentiation of naïve CD4 T cells toward the Th1, Th2 and Th17 lineages. Genes Immun. 2011, 12(3):222-230.
34. Sonnenberg G.F., Nair M.G., Kirn T.J., Zaph C., Fouser L.A., Artis D. Pathological versus protective functions of IL-22 in airway inflammation are regulated by IL-17A. J. Exp. Med. 2010, 207(June (6)):1293-1305.
35. Steinman L. A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat. Med. 2007, 13(February (2)):139-145.
36. Vargas-Rojas M.I., Ramirez-Venegas A., Limón-Camacho L., Ochoa L., Hernandez-Zenteno R., Sansores R.H. Increase of Th17 cells in peripheral blood of patients with chronic obstructive pulmonary disease. Respir. Med. 2011, 105:1648-1654.
37. Wolk K., Witte E., Warszawska K., Schulze-Tanzil G., Witte K., Philipp S., Kunz S., Docke W.D., Asadullah K., Volk H.D., Sterry W., Sabat R. The Th17 cytokine IL-22 induces IL-20 production in keratinocytes: a novel immunological cascade with potential relevance in psoriasis. Eur. J. Immunol. 2009, 39(December (12)):3570-3581.